Identification of Sorafenib as a Treatment for Type 1 Diabetes.
Zeng Q, Song J, Wang D, Sun X, Xiao Y, Zhang H, Xiao Y, Zhou Z, Deng T.
Zeng Q, et al. Among authors: xiao y.
Front Immunol. 2022 Feb 15;13:740805. doi: 10.3389/fimmu.2022.740805. eCollection 2022.
Front Immunol. 2022.
PMID: 35242127
Free PMC article.